Hereditary Angioedema Market Size, Trends, and Growth Opportunities 2025-2032
The hereditary angioedema (HAE) market is witnessing robust growth, driven by increased market insights into rare genetic disorders and advances in targeted therapies. The continual market evolution reflects growing industry share by innovative market players addressing unmet patient needs.
Hereditary Angioedema Market size is estimated to be valued at USD 3.13 Bn in 2025 and is expected to reach USD 5.96 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.
Hereditary Angioedema Market Forecast is propelled by market drivers such as rising prevalence of HAE, advancements in biologics, and increased market revenue streams from new therapy launches. Market trends also indicate shifts toward personalized treatment approaches, expanding the overall market scope and further enhancing industry size.
Get More Insights On- Hereditary Angioedema Market
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian